Late Occurrence of Multiple Bone Metastasis in Patient with Well Controlled Advanced Pancreatic Cancer

  • Min Cheol Kim (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Da Eun Jeong (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Joon Hyuk Choi (Department of Pathology, Yeungnam University College of Medicine) ;
  • Tae Nyeun Kim (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine)
  • Received : 2016.06.03
  • Accepted : 2016.06.14
  • Published : 2016.06.30

Abstract

A 67-year-old male was admitted due to abdominal pain. Abdominal CT scan performed in a local clinic showed about 2 cm sized pancreatic tail mass with extensive liver and multiple regional lymph node metastasis. Histology of liver biopsy revealed poorly differentiated adenocarcinoma. He underwent chemotherapy with gemcitabine and erlotinib for 5 cycles followed by 8 cycles of second line chemotherapy with 5-fluorouracil and cisplatin. At 12 months after diagnosis, follow-up abdominal CT scan revealed marked reduction of tumor mass in the liver and pancreas with small residual tumor. After one month of last chemotherapy, he complained radiating pain along left leg. Blood chemistry revealed isolated elevation of alkaline phosphatase (ALP) and multiple bone metastasis were demonstrated in bone scan. Palliative radiation therapy to pelvic bone was performed for the relief of bone pain. The prognosis of advanced pancreatic cancer is extremely poor. We report late occurrence of multiple bone metastasis in a patient with well controlled advanced pancreatic cancer with chemotherapy.

Keywords

References

  1. Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nature Reviews Clinical Oncology 2010;7:163-172.
  2. Jung K-W, Won Y-J, Kong H-J, Oh C-M, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Research and Treatment 2014;46:109-123.
  3. Heinemann V, Boeck S, Hinke A, Labianca R, Louvet C. Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer. BMC Cancer 2008;8:1.
  4. Borad MJ, Saadati H, Lakshmipathy A, et al. Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature. Yale J Biol Med 2009;82:1-6.
  5. Saif MW, Brennan M, Penney R, Hotchkiss S, Kaley K. Cutaneous metastasis in a patient with pancreatic cancer. JOP Journal of the Pancreas 2011;12:306-308.
  6. Saif MW, Galanina N, Ravage-Mass L, et al. Bone metastasis as the only metastatic site in a patient with pancreatic cancer following distal pancreatectomy. Case reports in medicine 2010;2010.
  7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians 2015;65:5-29.
  8. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. Journal of the American College of Surgeons 1999;189:1-7.
  9. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. The Lancet 2011;378:607-620.
  10. Pneumaticos S, Savidou C, Korres D, Chatziioannou S. Pancreatic cancer's initial presentation: back pain due to osteoblastic bone metastasis. European journal of cancer care 2010;19:137-140.
  11. Iguchi H, Yasuda M, Matsuo T, Sumii T, Funakoshi A. [Clinical features and management of pancreatic cancer with bone metastases]. Nihon Shokakibyo Gakkai zasshi=The Japanese Journal of Gastro-enterology 2004;101:872-878.
  12. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114-1117.
  13. Campbell PJ, Yachida S, Mudie LJ, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010;467:1109-1113.